↑ Rising
Business
🔮 holds ✗
Novo
14 independently sourced, verified news trends involving Novo.
Coverage evidence
This hub is built from stories supported by at least four independent sources and accepted by Newsylist's verification pass. Qualifying coverage spans 1 news category, from Sep 14, 2026 through Nov 5, 2026.
Open any card for the source list, timeline and coverage-velocity evidence. Raw detections and extractive-only records are excluded from this page.
◼ Archived
Business
🔮 holds ✗
Novo's next-generation obesity drug shows 25% weight loss in women in late-stage analysis
◼ Archived
Business
🔮 fades ✓
Patients switching to Novo Nordisk's Wegovy pill from shots lose more weight in real-world study
◼ Archived
Business
🔮 holds ✗
Novo Nordisk to Pay Up to $1.3 Billion for Nanexa’s Drug Delivery Technology
◼ Archived
Business
🔮 holds ✗
Novo is betting on its next chapter as Eli Lilly gains more ground in GLP-1s
◼ Archived
Business
🔮 holds ✗
Viking Therapeutics Skyrockets On Obesity Drug Data. Eli Lilly, Novo Fall.
◼ Archived
Business
🔮 holds ✗
GLP-1 makers Novo, Eli Lilly sued over sudden loss of vision in patients
◼ Archived
Business
🔮 holds ✗
Novo defends diversification push as CEO eyes deals beyond obesity
◼ Archived
Business
🔮 holds ✗
Novo says CagriSema shows greater weight loss than Lilly rival in diabetes patients
◼ Archived
Business
🔮 holds ✗
AMD, Intel, Novo, Meta, Strategy, Critical Metals, and More Stocks That Explain Today’s Market
◼ Archived
Business
🔮 holds ✗
Wegovy-maker Novo faces calls to map out strategy beyond weight-loss drugs
◼ Archived
Business
🔮 holds ✗
Novo explores macrocycles’ potential in $1.4B cardiometabolic pact with Danish biotech
◼ Archived
Business
🔮 fades ✓
Novo Nordisk Will Use Anthropic’s Claude for Drug Research
◼ Archived
Business
🔮 holds ✗